Register now for the next episode of “Dr. Gilbert Hosts” where APDA’s Chief Scientific Officer, Dr. Rebecca Gilbert, speaks with Dr. Clemens Scherzer.  Dr. Scherzer will discuss his innovative research, address many of the fascinating issues about genetics as it relates to PD.  The webinar is scheduled for Wednesday, March 17, 9am PT.

In this ongoing webinar series by the American Parkinson Disease Association (APDA), Dr. Gilbert speaks with experts in the Parkinson’s disease (PD) community and opens the conversation up to your questions. 

Dr. Gilbert Hosts: Genetics & PD with Dr. Clemens Scherzer

Wednesday, March 17, 2021

12:00 PM ET
11:00 AM CT
10:00 AM MT
 9:00 AM PT
Register Today

This webinar will be conducted via Zoom. After registering, you will receive a confirmation email containing information about how to join the webinar, including a Zoom link.

About Dr. Clemens Scherzer

Dr. Scherzer is Professor of Neurology at Harvard Medical School and Director of the APDA Center for Advanced Research at Brigham & Women’s Hospital. Dr. Scherzer is a graduate of the University of Vienna Medical School and then completed his Neurology residency at Emory University, and Movement disorders fellowship training at Harvard. Dr. Scherzer is a pioneer in precision neurology using massive data streams from genomes, transcriptomes, and longitudinal cohorts to predict and prevent progression of PD. His research has led to the discovery of genetic drivers, biomarkers, and therapeutic mechanisms of PD, and is inspiring clinical trials. He leads the Harvard Biomarkers Study, with 3,000 participants – one of the largest longitudinal biobanks for PD in the world. He serves on APDA’s Scientific Advisory Board. His work was recognized by the Dr. Paul Beeson and the George C. Cotzias Memorial Awards, and has been featured in Science, Scientific American, The Washington Post, US News & World Report, and NOVA Next.